Consun Pharmaceutical Group Limited (FRA:C1P)
Germany flag Germany · Delayed Price · Currency is EUR
1.600
0.00 (0.00%)
Last updated: Sep 9, 2025, 8:09 AM CET

FRA:C1P Statistics

Total Valuation

FRA:C1P has a market cap or net worth of EUR 1.44 billion. The enterprise value is 1.02 billion.

Market Cap1.44B
Enterprise Value 1.02B

Important Dates

The last earnings date was Friday, August 22, 2025.

Earnings Date Aug 22, 2025
Ex-Dividend Date Sep 4, 2025

Share Statistics

Current Share Class 829.09M
Shares Outstanding n/a
Shares Change (YoY) +6.04%
Shares Change (QoQ) +0.40%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 445.28M

Valuation Ratios

The trailing PE ratio is 11.97 and the forward PE ratio is 10.37.

PE Ratio 11.97
Forward PE 10.37
PS Ratio 3.70
PB Ratio 2.60
P/TBV Ratio 2.96
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 8.48
EV / Sales 2.59
EV / EBITDA 7.56
EV / EBIT 7.90
EV / FCF n/a

Financial Position

The company has a current ratio of 3.54, with a Debt / Equity ratio of 0.05.

Current Ratio 3.54
Quick Ratio 3.29
Debt / Equity 0.05
Debt / EBITDA 0.23
Debt / FCF n/a
Interest Coverage 76.73

Financial Efficiency

Return on equity (ROE) is 23.60% and return on invested capital (ROIC) is 14.26%.

Return on Equity (ROE) 23.60%
Return on Assets (ROA) 11.58%
Return on Invested Capital (ROIC) 14.26%
Return on Capital Employed (ROCE) 22.61%
Revenue Per Employee 126,376
Profits Per Employee 39,027
Employee Count3,164
Asset Turnover 0.56
Inventory Turnover 2.35

Taxes

In the past 12 months, FRA:C1P has paid 12.14 million in taxes.

Income Tax 12.14M
Effective Tax Rate 9.11%

Stock Price Statistics

The stock price has increased by +166.67% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change +166.67%
50-Day Moving Average 1.32
200-Day Moving Average 1.06
Relative Strength Index (RSI) 74.49
Average Volume (20 Days) 1,302

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, FRA:C1P had revenue of EUR 388.35 million and earned 119.93 million in profits. Earnings per share was 0.14.

Revenue388.35M
Gross Profit 297.54M
Operating Income 127.52M
Pretax Income 133.29M
Net Income 119.93M
EBITDA 133.29M
EBIT 127.52M
Earnings Per Share (EPS) 0.14
Full Income Statement

Balance Sheet

The company has 479.88 million in cash and 30.11 million in debt, giving a net cash position of 449.77 million.

Cash & Cash Equivalents 479.88M
Total Debt 30.11M
Net Cash 449.77M
Net Cash Per Share n/a
Equity (Book Value) 552.29M
Book Value Per Share 0.61
Working Capital 406.30M
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 76.62%, with operating and profit margins of 32.84% and 30.88%.

Gross Margin 76.62%
Operating Margin 32.84%
Pretax Margin 34.32%
Profit Margin 30.88%
EBITDA Margin 34.32%
EBIT Margin 32.84%
FCF Margin n/a

Dividends & Yields

This stock pays an annual dividend of 0.07, which amounts to a dividend yield of 4.88%.

Dividend Per Share 0.07
Dividend Yield 4.88%
Dividend Growth (YoY) -34.36%
Years of Dividend Growth 2
Payout Ratio n/a
Buyback Yield -6.04%
Shareholder Yield -1.17%
Earnings Yield 8.36%
FCF Yield n/a
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 5